Probe Clinical Research Corporation

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)	Apnea, Body Weight, Dyssomnias, Neurologic Manifestations, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Signs and Symptoms, Signs and Symptoms, Respiratory, Sleep Disorders, Sleep Disorders, Intrinsic, nervous system disorder, nutritional disorder, obesity disorder, overnutrition, psychiatric disorder, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder	Recruiting	Phase 3	2026-10-08		NCT07823608
Continuation Protocol for Obstructive Sleep Apnea (OSA)	Apnea, Dyssomnias, Respiration Disorders, Sleep Disorders, Intrinsic, nervous system disorder, obstructive sleep apnea syndrome, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder	Enrolling by invitation	Phase 3	2025-05-13		NCT06566820

Clinical trials